Ho Ching-Liang相关文献与解析，生知库 | 链接生命科学的每一步

Effectiveness of a Social Media-Based Life Review Intervention on Happiness in Advanced Cancer Patients and Their Family Caregivers: A Mixed-Methods Study

社交媒体生命回顾干预对晚期癌症患者及其家庭照护者幸福感的影响：一项混合方法研究

期刊:Psycho-Oncology

影响因子:3.5

doi:10.1002/pon.70374

Yang, Wen-Chi; Li, Chung-Yi; Ho, Ching-Liang; Chang, Ping-Ying; Wu, Li-Fen; Pan, Hsueh-Hsing

A nomogram for predicting recurrence-free survival in patients with high-risk GIST receiving adjuvant imatinib: A nationwide registry study

用于预测接受伊马替尼辅助治疗的高危胃肠道间质瘤患者无复发生存期的列线图：一项全国性注册研究

期刊:

影响因子:

doi:10.3892/etm.2026.13140

Yeh, Chun-Nan; Shan, Yan-Shen; Yang, Ching-Yao; Hsiao, Chin-Fu; Tsai, Chung-Hsin; Wang, Chuan-Cheng; Lin, Ming-Tsan; Ting, Chun-Fu; Chan, De-Chuan; Chen, Te-Hung; Yen, Chueh-Chuan; Chen, Yen-Yang; Lin, Hsuan-Yu; Yeh, Ta-Sen; Ho, Ching-Liang; Shieh, Tze-Yu; Bai, Li-Yaun; Hsu, Jun-Te; Chen, I-Shu; Chen, Li-Tzong; Tsai, Hui-Jen

发表日期：2026

文献求助收藏

Total neoadjuvant therapy for locally advanced rectal cancer

局部晚期直肠癌的新辅助治疗

期刊:Cochrane Database of Systematic Reviews

影响因子:9.4

doi:10.1002/14651858.CD015590

Mueller, Sophie; Kao, Yung-Shuo; Kastner, Carolin; Chen, Po-Huang; Hendricks, Anne; Lee, Gin Yi; Koehler, Franziska; Jhou, Hong-Jie; Germer, Christoph-Thomas; Kang, Enoch Yi-No; Janka, Heidrun; Ho, Ching-Liang; Lee, Cho-Hao; Wiegering, Armin

UFUR maintenance therapy significantly improves survival in locally advanced head and neck squamous cell carcinoma following definitive chemoradiotherapy

UFUR维持治疗可显著提高局部晚期头颈部鳞状细胞癌患者在根治性放化疗后的生存率。

期刊:Cancer Cell International

影响因子:6

doi:10.1186/s12935-025-03807-w

Hsieh, Jason Chia-Hsun; Lien, Ming-Yu; Chang, Pei-Hung; Wang, Hung-Ming; Yeh, Kun-Yun; Ho, Ching-Liang; Hsieh, Ching-Yun; Hsieh, Meng-Che; Chen, Jia-Hong

Clinical outcomes of gastroenteropancreatic neuroendocrine neoplasms in Taiwan: A multicenter registry study-TCOG T1214 study.

台湾胃肠胰神经内分泌肿瘤的临床结果：一项多中心注册研究——TCOG T1214 研究

期刊:Cancer

影响因子:5.1

doi:10.1002/cncr.70019

Tsai Hui-Jen, Chen Ming-Huang, Wang Hsiu-Po, Hsiao Chin-Fu, Chen Yen-Yang, Chen Jen-Shi, Yang Mei-Due, Tzen Chin-Yuan, Shan Yan-Shen, Bai Li-Yaun, Chan De-Chuan, Chu Pei-Yi, Ho Ching-Liang, Yang Youngsen, Lin Johnson, Lin Hsuan-Yu, Chang Cheng-Shyong, Wang Chuan-Cheng, Hwang Tsann-Long, Chen Li-Tzong

Temporal Trends of Hyponatremia in Patients with Respiratory and Intrathoracic Cancers Treated with Chemotherapy and Immune Checkpoint Inhibitors

接受化疗和免疫检查点抑制剂治疗的呼吸系统和胸腔内肿瘤患者低钠血症的时间趋势

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers17091459

Lu, Kuo-Cheng; Ho, Ching-Liang; Wang, Joshua; Zheng, Cai-Mei; Tsai, Kuo-Wang; Hou, Yi-Chou; Lu, Chien-Lin

A pilot study of tegafur-uracil maintenance on survival in patients with esophageal squamous cell carcinoma following definitive chemoradiotherapy

一项关于替加氟-尿嘧啶维持治疗对接受根治性放化疗的食管鳞状细胞癌患者生存期影响的初步研究

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-30353-2

Huang, Tzu-Chuan; Chen, Jia-Hong; Hsieh, Jason Chia-Hsun; Lien, Ming-Yu; Ho, Ching-Liang; Chang, Pei-Hung; Hsieh, Meng-Che

Immune checkpoint inhibitor therapy and risk of type 1 diabetes mellitus in metastatic cancer patients

免疫检查点抑制剂治疗与转移性癌症患者发生1型糖尿病的风险

期刊:Diabetology & Metabolic Syndrome

影响因子:3.9

doi:10.1186/s13098-025-01940-0

Lin, Ming-Hsun; Ye, Ren-Hua; Jhou, Hong-Jie; Chen, Hsin-Yu; Kao, Li-Ting; Hsieh, Tina Yi-Jin; Chen, Yu-Han; Yue-En Sun, Andrea; Zhang, Xiaoyi; Dai, Ming-Shen; Ho, Ching-Liang; Chen, Po-Huang; Lee, Cho-Hao

Durvalumab, Tremelimumab, and Platinum Chemotherapy in EGFR Mutation-Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE)

Durvalumab、Tremelimumab 和铂类化疗治疗 EGFR 突变阳性非小细胞肺癌：一项开放标签 2 期试验 (ILLUMINATE)

期刊:JTO Clinical and Research Reports

影响因子:3.5

doi:10.1016/j.jtocrr.2024.100771

Lee, Chee Khoon; Liao, Bin-Chi; Subramaniam, Shalini; Chiu, Chao-Hua; Mersiades, Antony J; Ho, Chao-Chi; Brown, Chris; Lai, Chun-Liang; Hughes, Brett G M; Yang, Tsung-Ying; O'Byrne, Ken; Luo, Yung-Hung; Yip, Sonia; Ho, Ching-Liang; Bray, Victoria; Su, Wu-Chou; Moore, Melissa; Feng, Wei-Lien; Bai, Ya-Ying; Ford, Kate; Cummins, Michelle M; Stockler, Martin R; Solomon, Benjamin J; John, Thomas; Chih-Hsin Yang, James

Early intervention for high-risk smoldering multiple myeloma (SMM)

对高危冒烟型多发性骨髓瘤（SMM）进行早期干预

Effectiveness of a Social Media-Based Life Review Intervention on Happiness in Advanced Cancer Patients and Their Family Caregivers: A Mixed-Methods Study

社交媒体生命回顾干预对晚期癌症患者及其家庭照护者幸福感的影响：一项混合方法研究

A nomogram for predicting recurrence-free survival in patients with high-risk GIST receiving adjuvant imatinib: A nationwide registry study

用于预测接受伊马替尼辅助治疗的高危胃肠道间质瘤患者无复发生存期的列线图：一项全国性注册研究

Total neoadjuvant therapy for locally advanced rectal cancer

局部晚期直肠癌的新辅助治疗

UFUR maintenance therapy significantly improves survival in locally advanced head and neck squamous cell carcinoma following definitive chemoradiotherapy

UFUR维持治疗可显著提高局部晚期头颈部鳞状细胞癌患者在根治性放化疗后的生存率。

Clinical outcomes of gastroenteropancreatic neuroendocrine neoplasms in Taiwan: A multicenter registry study-TCOG T1214 study.

台湾胃肠胰神经内分泌肿瘤的临床结果：一项多中心注册研究——TCOG T1214 研究

Temporal Trends of Hyponatremia in Patients with Respiratory and Intrathoracic Cancers Treated with Chemotherapy and Immune Checkpoint Inhibitors

接受化疗和免疫检查点抑制剂治疗的呼吸系统和胸腔内肿瘤患者低钠血症的时间趋势

A pilot study of tegafur-uracil maintenance on survival in patients with esophageal squamous cell carcinoma following definitive chemoradiotherapy

一项关于替加氟-尿嘧啶维持治疗对接受根治性放化疗的食管鳞状细胞癌患者生存期影响的初步研究

Immune checkpoint inhibitor therapy and risk of type 1 diabetes mellitus in metastatic cancer patients

免疫检查点抑制剂治疗与转移性癌症患者发生1型糖尿病的风险

Durvalumab, Tremelimumab, and Platinum Chemotherapy in EGFR Mutation-Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE)

Durvalumab、Tremelimumab 和铂类化疗治疗 EGFR 突变阳性非小细胞肺癌：一项开放标签 2 期试验 (ILLUMINATE)